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. Antibodies used in this work. Table S2 . Primers for quantitative reverse transcript-PCR (qRT-PCR). Table S3 . Target sequences of short hairpin RNA (shRNA). Table S4 . Primers for chromatin immunoprecipitation-qPCR (ChIP-qPCR). Figure S1 . Cell proliferation, genomic DNA 5-hydroxymethylcytosine (5hmC) level and teneleven translocation 2 (TET2) expression of MCF-7 breast cancer cells upon 17-beta-estradiol (E 2 ) or bisphenol A/S (BPA/BPS) exposure. (A) MTS assay of MCF-7 proliferation induced by E 2 and BPA/BPS. (B) Relative level of genomic 5hmC measured by ELISA assay of genomic DNA from MCF-7 cells exposed to E 2 or BPA/BPS. Mean and corresponding ± SD (of three replicates) were shown for each treatment. (C) qRT-PCR analysis of the expression of TET2 in MCF-7 cells after 48 h of vehicle, E 2 , or BPA/BPS treatment. (D, E) Immunoprecipitation and quantitative analysis of TET1, TET2 and TET3 proteins in MCF-7 cells at 48 h of E 2 and BPA/BPS treatment. The relative intensity was calculated by the ratio relative to the GAPDH intensity. Data represent mean ± SD of three independent experiments. Statistical analysis was performed with two-way ANOVA (Bonferroni posttest). *, P < 0.05 or **, P < 0.01 vs control of 24 h (A, B) or vs control (C-E); #, P < 0.05 vs indicated samples (A, B). Figure S9 . Interaction of ERα with ten-eleven translocation 2 (TET2) protein in bisphenol A/S (BPA/BPS) exposed MCF7 cells, showing no detectable interaction of ERα and TET2. Immunoprecipitation was performed using anti-ERα antibody followed by western blotting with indicated antibodies. Sp1 protein, the co-factor of ERα, was used as the positive control. 
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